ArticleExperimental hematology & oncology2022

Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma.

Staci L Haney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.